UZ Leuven is building the first protontherapy center in Belgium
SCANNIX is proud to annonce that we provide the global radiomonitoring system for the first protontherapy center in Belgium at UZ Leuven. This center, wich should be finsihed in 2019, will consist of a clinic for the treatment of patients and a protected site for advanced research.
SCANNIX joins BAM Constructors, SPIE and IBA to carry out this first protontherapy center in Belgium.
Protontherapy is an innovative type of radiotherapy that radiates malignant tumours with proton beams with as little damage to the healthy surrounding tissue as possible.
IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, has provided the 2 Proteus One cyclotron that will operate treatement in the first center in Belgium.
Scannix will use the well known LUDLUM‘s monitoring system and his new PRESCILA neutron probe to measure the emission of neutron and gamma during the patient treatment.
The Ludlum Model 42-41L PRESCILA Neutron Detector is a viable and ergonomically superior alternative to traditional REM-ball designs for handheld radiation surveys and Radiomonitoring system. It has been developed and proven through extensive performance and field testing by the Health, Safety, and Radiation Protection Division of Los Alamos National Laboratory (LANL).
Unlike the traditional neutron detector using He3 tube the PRESCILA detector uses a new scintillator technology with different kind of compact moderators. This technology allow to obtain a low-weight and very compact probe capable of excellent sensitivity for 241AmBe and extended energy response for thermal neutron over 300 MeV. Directional response is uniform (± 15%) over a wide range of energies. Response linearity has been characterized to a dose rate exceeding 20 mSv/h.
All these features makes the PRESCILA the ideal detector for Protontherapy cyclotron that generates neutron beam up to 230MeV.